PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Clinical trial NCT07023848 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07023848
Sponsor: Affiliated Hospital of Jiangnan University
Status: ENROLLING_BY_INVITATION
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Gastric Cancer (GC)Urothelial Carcinoma (UC)

Start date: 2025-07-01
Primary completion: 2026-07-07
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.